219 related articles for article (PubMed ID: 34363310)
1. Reinforcing the Induction of Immunogenic Cell Death Via Artificial Engineered Cascade Bioreactor-Enhanced Chemo-Immunotherapy for Optimizing Cancer Immunotherapy.
Sun K; Hu J; Meng X; Lei Y; Zhang X; Lu Z; Zhang L; Wang Z
Small; 2021 Sep; 17(37):e2101897. PubMed ID: 34363310
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy.
Ren H; Yong J; Yang Q; Yang Z; Liu Z; Xu Y; Wang H; Jiang X; Miao W; Li X
Acta Pharm Sin B; 2021 Oct; 11(10):3244-3261. PubMed ID: 34729313
[TBL] [Abstract][Full Text] [Related]
3. Two-pronged microenvironmental modulation of metal-oxidase cascade catalysis and metabolic intervention for synergistic tumor immunotherapy.
Song Q; Gao H; Sun S; Li Y; Wu X; Yang J; Wang B; Zhang Y; Wang L
Acta Biomater; 2024 Jan; 173():378-388. PubMed ID: 37925121
[TBL] [Abstract][Full Text] [Related]
4. Genetically Edited Cascade Nanozymes for Cancer Immunotherapy.
Zhang J; Pan Y; Liu L; Xu Y; Zhao C; Liu W; Rao L
ACS Nano; 2024 May; 18(19):12295-12310. PubMed ID: 38695532
[TBL] [Abstract][Full Text] [Related]
5. Crizotinib prodrug micelles co-delivered doxorubicin for synergistic immunogenic cell death induction on breast cancer chemo-immunotherapy.
Liang Q; Lan Y; Li Y; Cao Y; Li J; Liu Y
Eur J Pharm Biopharm; 2022 Aug; 177():260-272. PubMed ID: 35863668
[TBL] [Abstract][Full Text] [Related]
6. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y
Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor-Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer Immunotherapy.
Huang C; Lin B; Chen C; Wang H; Lin X; Liu J; Ren Q; Tao J; Zhao P; Xu Y
Adv Mater; 2022 Dec; 34(51):e2207593. PubMed ID: 36245299
[TBL] [Abstract][Full Text] [Related]
8. A Multifunctional Cascade Bioreactor Based on Hollow-Structured Cu
Chang M; Wang M; Wang M; Shu M; Ding B; Li C; Pang M; Cui S; Hou Z; Lin J
Adv Mater; 2019 Dec; 31(51):e1905271. PubMed ID: 31680346
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Immunogenic Cell Death and Antigen Presentation
He T; Wang L; Gou S; Lu L; Liu G; Wang K; Yang Y; Duan Q; Geng W; Zhao P; Luo Z; Cai K
ACS Nano; 2023 Jun; 17(11):9953-9971. PubMed ID: 37212750
[TBL] [Abstract][Full Text] [Related]
10. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronidase-Functionalized Silica Nanocarrier for Enhanced Chemo-Immunotherapy through Inducing Immunogenic Cell Death.
Liu Q; Sun Y; Yin X; Li J; Xie J; Xie M; Wang K; Wu S; Li Y; Hussain M; Jiang B; Liu Y; Huang C; Tao J; Zhu J
ACS Appl Bio Mater; 2020 May; 3(5):3378-3389. PubMed ID: 35025380
[TBL] [Abstract][Full Text] [Related]
12. Cooperative Self-Assembled Nanoparticle Induces Sequential Immunogenic Cell Death and Toll-Like Receptor Activation for Synergistic Chemo-immunotherapy.
Wang Y; Wang Z; Chen B; Yin Q; Pan M; Xia H; Zhang B; Yan Y; Jiang Z; Zhang Q; Wang Y
Nano Lett; 2021 May; 21(10):4371-4380. PubMed ID: 33984236
[TBL] [Abstract][Full Text] [Related]
13. A manganese-phenolic network platform amplifying STING activation to potentiate MRI guided cancer chemo-/chemodynamic/immune therapy.
Pang X; Fu C; Chen J; Su M; Wei R; Wang Y; Lin W; Wei X; Jiang X; Yang X; Yang H; Wang J; Yang R
Biomater Sci; 2023 May; 11(11):3840-3850. PubMed ID: 37074080
[TBL] [Abstract][Full Text] [Related]
14. Binary regulation of the tumor microenvironment by a pH-responsive reversible shielding nanoplatform for improved tumor chemo-immunotherapy.
Sun X; Zhang J; Zhao X; Yang C; Shi M; Zhang B; Hu H; Qiao M; Chen D; Zhao X
Acta Biomater; 2022 Jan; 138():505-517. PubMed ID: 34798317
[TBL] [Abstract][Full Text] [Related]
15. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy.
Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D
Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594
[TBL] [Abstract][Full Text] [Related]
16. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
[TBL] [Abstract][Full Text] [Related]
17. Cascade Catalytic Nanoplatform Based on "Butterfly Effect" for Enhanced Immunotherapy.
Shao Y; Wang Z; Hao Y; Zhang X; Wang N; Chen K; Chang J; Feng Q; Zhang Z
Adv Healthc Mater; 2021 Apr; 10(8):e2002171. PubMed ID: 33448146
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable Manganese-Doped Calcium Phosphate Nanotheranostics for Traceable Cascade Reaction-Enhanced Anti-Tumor Therapy.
Fu LH; Hu YR; Qi C; He T; Jiang S; Jiang C; He J; Qu J; Lin J; Huang P
ACS Nano; 2019 Dec; 13(12):13985-13994. PubMed ID: 31833366
[TBL] [Abstract][Full Text] [Related]
19. Tumor Microenvironment-Activated Nanocomposite for Self-Amplifying Chemodynamic/Starvation Therapy Enhanced IDO-Blockade Tumor Immunotherapy.
Bian Y; Liu B; Ding B; Wang M; Yuan M; Ma P; Lin J
Adv Sci (Weinh); 2023 Dec; 10(34):e2303580. PubMed ID: 37807763
[TBL] [Abstract][Full Text] [Related]
20. A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody.
Li Z; Cai H; Li Z; Ren L; Ma X; Zhu H; Gong Q; Zhang H; Gu Z; Luo K
Bioact Mater; 2023 Mar; 21():299-312. PubMed ID: 36157245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
